CRL EBITDA | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) EBITDA

2026-06-27: Basis Reported; EBITDA $187.18M; Operating income (m); Depreciation and amortization (m).
2026-03-28: Basis Reported; EBITDA $187.05M; Operating income (m); Depreciation and amortization (m).
2025-12-27: Basis Reported; EBITDA -$205.16M; Operating income (m); Depreciation and amortization (m).
2025-09-27: Basis Reported; EBITDA $218.96M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2008-12-27 to 2026-06-27
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-27	Reported	$187.18M	(m)	(m)	(m)	18.64%	(m)	$179.72M*	(m)	(m)	$228.90M	$53.93M
2026-03-28	Reported	$187.05M	(m)	(m)	(m)	18.78%	(m)	$41.08M	(m)	(m)	$159.42M	-$15.14M
2025-12-27	Reported	-$205.16M	(m)	(m)	(m)	-20.64%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-27	Reported	$218.96M	(m)	(m)	(m)	21.79%	(m)	$213.83M*	(m)	(m)	$177.59M	$31.64M
2025-06-28	Reported	$219.64M	(m)	(m)	(m)	21.28%	(m)	$204.60M*	(m)	(m)	$191.55M	$18.73M
2025-03-29	Reported	$195.03M	(m)	(m)	(m)	19.82%	(m)	$171.70M	(m)	(m)	$177.80M	$10.10M
2024-12-28	Reported	-$65.58M	(m)	(m)	(m)	-6.54%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-28	Reported	$205.6M	(m)	(m)	(m)	20.36%	(m)	$251.79M*	$660.74M	(m)	$199.21M	$20.95M
2024-06-29	Reported	$237.73M	(m)	(m)	(m)	23.17%	(m)	$193.53M*	$672.40M	(m)	$169.79M	$25.39M
2024-03-30	Reported	$211.33M	(m)	(m)	(m)	20.89%	(m)	$129.89M	$666.72M	(m)	$186.29M	$24.53M
2023-12-30	Reported	$213.44M	(m)	(m)	(m)	21.06%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$230.37M	(m)	(m)	(m)	22.44%	(m)	$205.45M*	$664.78M	(m)	$176.11M	$24.85M
2023-07-01	Reported	$242.62M	(m)	(m)	(m)	22.89%	(m)	$148.12M*	$660.96M	(m)	$199.76M	$29.22M
2023-04-01	Reported	$244.96M	(m)	(m)	(m)	23.80%	(m)	$109.38M	$651.72M	(m)	$174.85M	$27.09M
2022-12-31	Reported	$241.36M	(m)	(m)	(m)	21.94%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-24	Reported	$225.58M	(m)	(m)	(m)	22.81%	(m)	$132.78M*	(m)	(m)	$183.71M	$25.50M
2022-06-25	Reported	$263.83M	(m)	(m)	(m)	27.11%	(m)	$149.47M*	(m)	(m)	$131.71M	$33.45M
2022-03-26	Reported	$224.08M	(m)	(m)	(m)	24.52%	(m)	$102.63M	(m)	(m)	$150.03M	$15.62M
2021-12-25	Reported	$240.05M	(m)	(m)	(m)	26.52%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-25	Reported	$224.49M	(m)	(m)	(m)	25.06%	(m)	$174.72M*	(m)	(m)	$148.57M	$18.11M
2021-06-26	Reported	$205.66M	(m)	(m)	(m)	22.49%	(m)	$186.59M*	(m)	(m)	$171.50M	$37.58M
2021-03-27	Reported	$185.21M	(m)	(m)	(m)	22.46%	(m)	$170.23M	(m)	(m)	$155.73M	$2.37M
2020-12-26	Reported	$189.8M	(m)	(m)	(m)	24.00%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-26	Reported	$192.33M	(m)	(m)	(m)	25.88%	(m)	$177.30M*	(m)	(m)	$128.29M	$32.66M
2020-06-27	Reported	$133.98M	(m)	(m)	(m)	19.63%	(m)	$162.31M*	(m)	(m)	$127.71M	$16.28M
2020-03-28	Reported	$151.54M	(m)	(m)	(m)	21.43%	(m)	$68.59M	(m)	(m)	$129.90M	$4.62M
2019-12-28	Reported	$160.62M	(m)	(m)	(m)	23.24%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-28	Reported	$144.56M	(m)	(m)	(m)	21.64%	(m)	$155.85M*	(m)	(m)	$129.51M	-$317.00K
2019-06-29	Reported	$128.91M	(m)	(m)	(m)	19.60%	(m)	$129.55M*	(m)	(m)	$135.94M	$14.69M
2019-03-30	Reported	$115.15M	(m)	(m)	(m)	19.05%	(m)	$14.86M	(m)	(m)	$122.57M	$10.60M
2018-12-29	Reported	$144.06M	(m)	(m)	(m)	23.95%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-29	Reported	$127.95M	(m)	(m)	(m)	21.86%	(m)	(m)	(m)	(m)	$113.03M	$12.40M
2018-06-30	Reported	$120.11M	(m)	(m)	(m)	20.52%	(m)	$123.87M*	(m)	(m)	$120.53M	$17.44M
2018-03-31	Reported	$101.04M	(m)	(m)	(m)	20.45%	(m)	$60.05M	(m)	(m)	$103.37M	$9.77M
2017-12-30	Reported	$96.31M	(m)	(m)	(m)	20.13%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$107.53M	(m)	(m)	(m)	23.16%	(m)	(m)	(m)	(m)	$92.43M	$19.95M
2017-07-01	Reported	$113.49M	(m)	(m)	(m)	24.19%	(m)	(m)	(m)	(m)	$93.82M	$22.24M
2017-04-01	Reported	$102.12M	(m)	(m)	(m)	22.91%	(m)	(m)	(m)	(m)	$90.91M	$31.08M
2016-12-31	Reported	$104.77M	(m)	(m)	(m)	22.44%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-24	Reported	$92.9M	(m)	(m)	(m)	21.82%	(m)	(m)	(m)	(m)	$85.65M	$15.56M
2016-06-25	Reported	$90.41M	(m)	(m)	(m)	20.83%	(m)	(m)	(m)	(m)	$100.47M	$18.84M
2016-03-26	Reported	$76.13M	(m)	(m)	(m)	21.45%	(m)	(m)	(m)	(m)	$82.94M	$13.97M
2015-12-26	Reported	$77.82M	(m)	(m)	(m)	21.99%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-26	Reported	$79.25M	(m)	(m)	(m)	22.68%	(m)	(m)	(m)	(m)	$76.22M	$15.26M
2015-06-27	Reported	$78.88M	(m)	(m)	(m)	23.23%	(m)	(m)	(m)	(m)	$71.33M	$11.08M
2015-03-28	Reported	$65.37M	(m)	(m)	(m)	20.40%	(m)	(m)	(m)	(m)	$71.40M	$331.00K
2014-12-27	Reported	$66.78M	(m)	(m)	(m)	20.26%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-27	Reported	$72.24M	(m)	(m)	(m)	22.05%	(m)	(m)	(m)	(m)	$64.48M	$11.58M
2014-06-28	Reported	$75.33M	(m)	(m)	(m)	22.08%	(m)	(m)	(m)	(m)	$67.76M	$14.08M
2014-03-29	Reported	$59.76M	(m)	(m)	(m)	19.96%	(m)	(m)	(m)	(m)	$64.77M	$10.36M
2013-12-28	Reported	$53.91M	(m)	(m)	(m)	18.64%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-28	Reported	$67.76M*	$40.84M	$26.92M*	(m)	(m)	(m)	(m)	(m)	(m)	$54.90M	$11.39M
2013-06-29	Reported	$63.60M*	$43.19M	$20.41M*	(m)	(m)	(m)	(m)	(m)	(m)	$54.92M	$8.22M
2013-03-30	Reported	$62.77M	(m)	(m)	(m)	21.55%	(m)	(m)	(m)	(m)	$57.20M	$9.72M
2012-12-29	Reported	$55.73M	(m)	(m)	(m)	19.89%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-29	Reported	$58.23M*	$37.68M	$20.55M*	(m)	(m)	(m)	(m)	(m)	(m)	$51.05M	$6.01M
2012-06-30	Reported	$69.34M*	$49.27M	$20.07M*	(m)	(m)	(m)	(m)	(m)	(m)	$49.90M	$9.45M
2012-03-31	Reported	$63.74M	(m)	(m)	(m)	22.29%	(m)	(m)	(m)	(m)	$55.98M	$8.68M
2011-12-31	Reported	$62.63M	(m)	(m)	(m)	21.52%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-24	Reported	$58.26M*	$37.09M	$21.17M*	(m)	(m)	(m)	(m)	(m)	(m)	$50.34M	$5.63M
2011-06-25	Reported	$75.13M*	$53.31M	$21.82M*	(m)	(m)	(m)	(m)	(m)	(m)	$47.21M	$8.65M
2011-03-26	Reported	$63.52M	(m)	(m)	(m)	22.22%	(m)	(m)	(m)	(m)	$55.01M	-$2.71M
2010-12-25	Reported	-$341.5M	(m)	(m)	(m)	-121.25%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-25	Reported	$29.95M*	$6.47M	$23.48M*	(m)	(m)	(m)	(m)	(m)	(m)	$48.01M	$16.67M
2010-06-26	Reported	$52.91M*	$29.98M	$22.93M*	(m)	(m)	(m)	(m)	(m)	(m)	$65.24M	$7.17M
2010-03-27	Reported	$53.77M	(m)	(m)	(m)	18.40%	(m)	(m)	(m)	(m)	$62.33M	$6.74M
2009-12-26	Reported	$54.87M	(m)	(m)	(m)	20.75%	(m)	(m)	(m)	(m)	(m)	(m)
2009-09-26	Reported	$69.28M*	$44.45M	$24.84M*	(m)	(m)	(m)	(m)	(m)	(m)	$54.13M	$6.90M
2009-06-27	Reported	(m)	$50.66M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$56.58M	$13.63M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-27	Reported	$428.47M	(m)	(m)	(m)	10.67%	(m)	$737.65M	(m)	(m)	$743.07M	$42.66M
2024-12-28	Reported	$589.09M	(m)	(m)	(m)	14.55%	(m)	$734.58M	(m)	(m)	$751.00M	$67.82M
2023-12-30	Reported	$931.39M	(m)	(m)	(m)	22.55%	(m)	$683.90M	(m)	(m)	$747.86M	$100.91M
2022-12-31	Reported	$954.85M	(m)	(m)	(m)	24.01%	(m)	$619.64M	(m)	(m)	$665.10M	$130.38M
2021-12-25	Reported	$855.4M	(m)	(m)	(m)	24.16%	(m)	$760.80M	(m)	(m)	$619.92M	$81.87M
2021-09-25	Rolling	(m)	$545.98M*	(m)	$3.43B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-26	Rolling	(m)	$522.93M*	(m)	$3.27B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-27	Rolling	(m)	$462.15M*	(m)	$3.04B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-26	Reported	$667.65M	(m)	(m)	(m)	22.83%	(m)	$546.58M	(m)	(m)	$528.93M	$81.81M
2020-12-26	Rolling	(m)	$432.73M*	(m)	$2.92B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-26	Rolling	(m)	$412.59M*	(m)	$2.82B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-27	Rolling	(m)	$372.64M*	(m)	$2.75B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-28	Rolling	(m)	$375.64M*	(m)	$2.72B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-28	Reported	$549.25M	(m)	(m)	(m)	20.95%	(m)	$480.94M	(m)	(m)	$517.62M	$50.02M
2019-12-28	Rolling	(m)	$351.15M*	(m)	$2.62B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-28	Rolling	(m)	$344.84M*	(m)	$2.53B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-29	Rolling	(m)	$336.40M*	(m)	$2.45B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-30	Rolling	(m)	$333.35M*	(m)	$2.38B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-29	Reported	$493.16M	(m)	(m)	(m)	21.76%	(m)	$441.14M	(m)	(m)	$443.85M	$54.46M
2018-12-29	Rolling	(m)	$331.38M*	(m)	$2.27B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-29	Rolling	(m)	$291.73M*	(m)	$2.14B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	$281.43M*	(m)	$2.02B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	$286.40M*	(m)	$1.91B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-30	Reported	$419.44M	(m)	(m)	(m)	22.58%	(m)	$318.07M	(m)	(m)	$371.27M	$171.37M
2017-12-30	Rolling	(m)	$288.28M*	(m)	$1.86B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	$294.55M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-07-01	Rolling	(m)	$279.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-04-01	Rolling	(m)	$255.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	$364.21M	(m)	(m)	(m)	21.66%	(m)	$316.90M	(m)	(m)	$364.71M	$66.83M
2016-12-31	Rolling	(m)	$237.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-24	Rolling	(m)	$220.60M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-25	Rolling	(m)	$217.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-26	Rolling	(m)	$214.92M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-26	Reported	$301.33M	(m)	(m)	(m)	22.10%	(m)	(m)	(m)	(m)	$300.41M	$43.39M
2015-12-26	Rolling	(m)	$206.45M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-26	Rolling	(m)	$194.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-27	Rolling	(m)	$185.68M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-28	Rolling	(m)	$180.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-27	Reported	$274.12M	(m)	(m)	(m)	21.12%	(m)	(m)	(m)	(m)	$269.03M	$47.67M
2014-12-27	Rolling	(m)	$177.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-27	Rolling	(m)	$161.51M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-28	Rolling	(m)	$156.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-29	Rolling	(m)	$148.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-28	Reported	$248.04M	(m)	(m)	(m)	21.28%	(m)	(m)	(m)	(m)	$225.69M	$32.91M
2013-12-28	Rolling	(m)	$151.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-29	Reported	$247.04M	(m)	(m)	(m)	21.87%	(m)	(m)	(m)	(m)	$208.25M	$27.63M
2011-12-31	Reported	$259.54M	(m)	(m)	(m)	22.71%	(m)	(m)	(m)	(m)	$198.65M	$17.14M
2010-12-25	Reported	-$204.86M	(m)	(m)	(m)	-18.07%	(m)	(m)	(m)	(m)	$232.49M	$23.00K
2009-12-26	Reported	$259.58M	(m)	(m)	(m)	22.15%	(m)	(m)	(m)	(m)	$227.66M	$40.35M
2008-12-27	Reported	-$364.99M	(m)	(m)	(m)	-28.18%	(m)	(m)	(m)	(m)	$223.94M	$57.03M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Medpace Holdings, Inc. (MEDP)	United States	$17.316B	30.09
INCYTE CORP (INCY)	United States	$24.855B	13.14
Absci Corp (ABSI)	United States	$1.775B	-14.92
OmniAb, Inc. (OABI)	United States	$0.698B	-8.05
NRC HEALTH (NRC)	United States	$0.450B	42.50
MAXCYTE, INC. (MXCT)	United States	$0.124B	-3.68
bioAffinity Technologies, Inc. (BIAF)	United States	$0.063B
OneMedNet Corp (ONMD)		$0.042B
iSpecimen Inc. (ISPC)	United States	$0.003B
FOXO TECHNOLOGIES INC. (FOXO)	United States	$0.000B	-277.71